Team
Experienced hands, a patient-first mission
Leadership spanning biopharma R&D, manufacturing, biophysics, and digital healthcare — united around precision therapies for cancer and infectious disease.
Praveen Kesava
Chairman
35+ years in digital healthcare, wellness, and cancer therapeutics; patient-first focus on democratizing access to care across cancer and infectious disease. Prior leadership at O.TM Biotech, DigitalDots, Exponential Machines, and a global healthcare role at IBM.
Dr. Vishvesh Kumar Bhupathiraju
President & CEO
35+ years across biopharma and academia in R&D and manufacturing. Postdoctoral work at UC Berkeley; PhD in Microbiology (University of Oklahoma). Senior roles incl. Biological E, Stelis Biopharma, Dr. Reddy's Laboratories, Bayer HealthCare, and research at UC Berkeley / Lawrence Berkeley National Lab.
Dr. Francis Fernandes
Chief Scientific Officer & Scientific Advisor
35+ years in biophysics, cancer therapeutics, and infectious disease. PhD in Biochemistry (Ohio University); 11 peer-reviewed publications. Prior science roles at O.TM Biotech (Founder & CSO), Mediclone Biotech, and Hoechst.
Advisors & Partners
XFBiologics collaborates with established R&D groups in the United States and Canada, and with contract manufacturers in the United Kingdom and Singapore — extending the platform with deep scientific and manufacturing expertise.